Company / Current Assets
Rani Therapeutics Holdings, Inc. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$53.3M
FY2025
5-year range
$29.7M / $119.6M
FY2021-FY2025
Trend
+79.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 2 years of decline, reaching $53M.
Based on SEC 10-K filings.
$53M in FY2025 with a 3-year CAGR of -19.2%.
Declined from $101M to $53M over the past 3 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -19.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -19.2%, indicating a declining trend.
- In FY2025, current assets increased 79.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $53.3M | +79.3% |
| FY2024 | $29.7M | -70.5% |
| FY2022 | $100.9M | -15.6% |
| FY2021 | $119.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026